Alterations in Pharmacokinetics of Gemcitabine and Erlotinib by Concurrent Administration of Hyangsayukgunja-Tang, a Gastroprotective Herbal Medicine
Gemcitabine and erlotinib are the chemotherapeutic agents used in the treatment of various cancers and their combination is being accepted as a first-line treatment of advanced pancreatic cancer. Hyangsayukgunja-tang (HYT) is a traditional oriental medicine used in various digestive disorders and po...
Main Authors: | Tae Hwan Kim, Soyoung Shin, Sarah Kim, Jürgen B. Bulitta, Kwon-Yeon Weon, Sang Hoon Joo, Eunsook Ma, Sun Dong Yoo, Gi-Young Park, Dong Rak Kwon, Seok Won Jeong, Da Young Lee, Beom Soo Shin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/22/9/1515 |
Similar Items
-
Regulation of appetite-related neuropeptides by herbal medicines: research using microarray and network pharmacology
by: Ji Hwan Lee, et al.
Published: (2023-10-01) -
Disposition of Erlotinib and Its Metabolite OSI420 in a Patient with High Bilirubin Levels
by: M. Czejka, et al.
Published: (2013-12-01) -
A Drug–Drug Interaction Study to Evaluate the Impact of Simvastatin and Itraconazole on Erlotinib Pharmacokinetics in Rats by UPLC-MS/MS
by: Fan Z, et al.
Published: (2023-10-01) -
Development of a Nanoliposomal Formulation of Erlotinib for Lung Cancer and in vitro/In vivo Antitumoral Evaluation [Retraction]
by: Zhou X, et al.
Published: (2022-11-01) -
Decreased absorption of midazolam in the stomach due to low pH induced by co-administration of Banha-sasim-tang
by: Jun Hyeon Jo, et al.
Published: (2016-08-01)